Review
Open access
Sep 2026
Overcoming melanoma drug resistance: Mechanisms and clinical progress of oncolytic viruses combined with immune checkpoint inhibitors (Review)
Emerging clinical evidence and mechanistic insights into OV–ICI synergy are synthesized to inform rational trial design, refine combination strategies, and accelerate the development of precision immuno-oncology approaches.
Yuan He, Wen-Xuan Lin, Hao-Fan Chen et al.
· Oncology Report · 0 citations